FAK, paxillin, and PI3K in ameloblastoma and adenomatoid odontogenic tumor.

Bello, Ibrahim O; Alrabeeah, Marwah A; AlFouzan, Naflaa F; Alabdulaali, Nora A; Nieminen, Pentti

Bello, Ibrahim O; Alrabeeah, Marwah A; AlFouzan, Naflaa F; Alabdulaali, Nora A; Nieminen, Pentti.

Afiliação

Bello IO; Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, King Saud University, Riyadh, 11545, Saudi Arabia. ibello@ksu.edu.sa.
Alrabeeah MA; Department of Pathology, University of Helsinki, Helsinki, Finland. ibello@ksu.edu.sa.
AlFouzan NF; College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
Alabdulaali NA; College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
Nieminen P; College of Dentistry, King Saud University, Riyadh, Saudi Arabia.

Clin Oral Investig ; 25(3): 1559-1567, 2021 Mar.

Article em En | MEDLINE | ID: mdl-32681423

Assuntos

Ameloblastoma; Tumores Odontogênicos; Quinase 1 de Adesão Focal; Humanos; Paxilina; Fosfatidilinositol 3-Quinases

Palavras-chave

Adenomatoid odontogenic tumor; Ameloblastoma; FAK; Focal adhesion kinase; PI3K; Paxillin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ameloblastoma / Tumores Odontogênicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google